Adjuvant temozolomide-based chemoradiotherapy versus radiotherapy alone in patients with WHO III astrocytoma: The Mainz experience.
about
Clinically significant CMV (re)activation during or after radiotherapy/chemotherapy of the brain : Correlation with neurological deterioration and improvement upon antiviral treatment.Frequent occurrence of therapeutically reversible CMV-associated encephalopathy during radiotherapy of the brain.Concurrent radiotherapy with temozolomide vs. concurrent radiotherapy with a cisplatinum-based polychemotherapy regimen : Acute toxicity in pediatric high-grade glioma patients.
P2860
Adjuvant temozolomide-based chemoradiotherapy versus radiotherapy alone in patients with WHO III astrocytoma: The Mainz experience.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Adjuvant temozolomide-based ch ...... ocytoma: The Mainz experience.
@en
type
label
Adjuvant temozolomide-based ch ...... ocytoma: The Mainz experience.
@en
prefLabel
Adjuvant temozolomide-based ch ...... ocytoma: The Mainz experience.
@en
P2093
P2860
P921
P1476
Adjuvant temozolomide-based ch ...... ocytoma: The Mainz experience.
@en
P2093
Arnulf Mayer
Carina Schwanbeck
Clemens Sommer
Heinz Schmidberger
Marcus Stockinger
Mirjam Renovanz
Peter Vaupel
P2860
P2888
P304
P356
10.1007/S00066-015-0855-X
P577
2015-05-30T00:00:00Z